(Q50659255)

English

Pregnenolone treatment reduces severity of negative symptoms in recent-onset schizophrenia: an 8-week, double-blind, randomized add-on two-center trial.

scientific article published on 18 February 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/24548129

Pregnenolone treatment reduces severity of negative symptoms in recent-onset schizophrenia: an 8-week, double-blind, randomized add-on two-center trial. (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/24548129

0 references

author name string

Michael S Ritsner

1

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/24548129

Hisham Bawakny

2

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/24548129

Anatoly Kreinin

3

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/24548129

publication date

18 February 2014

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/24548129

Psychiatry and Clinical Neurosciences

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/24548129

68

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/24548129

6

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/24548129

432-440

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/24548129

The neuropsychopharmacological potential of neuroactive steroids

1 reference

https://api.crossref.org/works/10.1111%2FPCN.12150

21 January 2018

Modulation of neurotransmitter systems by dehydroepiandrosterone and dehydroepiandrosterone sulfate: mechanism of action and relevance to psychiatric disorders

1 reference

https://api.crossref.org/works/10.1111%2FPCN.12150

21 January 2018

Neuroactive steroids modulate HPA axis activity and cerebral brain-derived neurotrophic factor (BDNF) protein levels in adult male rats

1 reference

https://api.crossref.org/works/10.1111%2FPCN.12150

21 January 2018

CSF neuroactive steroids in affective disorders: pregnenolone, progesterone, and DBI.

1 reference

https://api.crossref.org/works/10.1111%2FPCN.12150

21 January 2018

Differences in blood pregnenolone and dehydroepiandrosterone levels between schizophrenia patients and healthy subjects.

1 reference

https://api.crossref.org/works/10.1111%2FPCN.12150

21 January 2018

Proof-of-concept trial with the neurosteroid pregnenolone targeting cognitive and negative symptoms in schizophrenia

1 reference

https://api.crossref.org/works/10.1111%2FPCN.12150

21 January 2018

Pregnenolone, dehydroepiandrosterone, and schizophrenia: alterations and clinical trials.

1 reference

https://api.crossref.org/works/10.1111%2FPCN.12150

21 January 2018

Pregnenolone and dehydroepiandrosterone as an adjunctive treatment in schizophrenia and schizoaffective disorder: an 8-week, double-blind, randomized, controlled, 2-center, parallel-group trial

1 reference

https://api.crossref.org/works/10.1111%2FPCN.12150

21 January 2018

The clinical and therapeutic potentials of dehydroepiandrosterone and pregnenolone in schizophrenia

1 reference

https://api.crossref.org/works/10.1111%2FPCN.12150

21 January 2018

Adjunctive Pregnenolone Ameliorates the Cognitive Deficits in Recent-Onset Schizophrenia: An 8-Week, Randomized, Double-Blind, Placebo-Controlled Trial.

1 reference

https://api.crossref.org/works/10.1111%2FPCN.12150

21 January 2018

Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.

1 reference

https://api.crossref.org/works/10.1111%2FPCN.12150

21 January 2018

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

1 reference

https://api.crossref.org/works/10.1111%2FPCN.12150

21 January 2018

The positive and negative syndrome scale (PANSS) for schizophrenia

1 reference

https://api.crossref.org/works/10.1111%2FPCN.12150

21 January 2018

Chlorpromazine Equivalent Doses for the Newer Atypical Antipsychotics

1 reference

https://api.crossref.org/works/10.1111%2FPCN.12150

21 January 2018

Manual for the Extrapyramidal Symptom Rating Scale (ESRS).

1 reference

https://api.crossref.org/works/10.1111%2FPCN.12150

21 January 2018

The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS

1 reference

https://api.crossref.org/works/10.1111%2FPCN.12150

21 January 2018

Neuroactive steroids, mood stabilizers, and neuroplasticity: alterations following lithium and changes in Bcl-2 knockout mice

1 reference

https://api.crossref.org/works/10.1111%2FPCN.12150

21 January 2018

Longitudinal changes in dehydroepiandrosterone concentrations in men and women.

1 reference

https://api.crossref.org/works/10.1111%2FPCN.12150

21 January 2018

Age relationships and sex differences in serum levels of pregnenolone and 17-hydroxypregnenolone in healthy subjects

1 reference

https://api.crossref.org/works/10.1111%2FPCN.12150

21 January 2018

Treatment with dehydroepiandrosterone sulfate increases NMDA receptors in hippocampus and cortex

1 reference

https://api.crossref.org/works/10.1111%2FPCN.12150

21 January 2018

Pregnenolone protects mouse hippocampal (HT-22) cells against glutamate and amyloid beta protein toxicity

1 reference

https://api.crossref.org/works/10.1111%2FPCN.12150

21 January 2018

Identifiers

10.1111/PCN.12150

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/24548129

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/24548129

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50659255&oldid=811797593"